Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Murray

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical and Translational Radiation Oncology|July 26, 2019
Prostate cancer - Advantages and disadvantages of MR-guided RTJulia Murray, Alison C Tree
Frontiers in Oncology|February 27, 2026
Hydraulic endorectal actuator for prostate radiotherapy reduces variations in motion in a silicone rectal phantomAryan Niknam Maleki, Mark Runciman, Julia Murray, et al.
Current Medical Research and Opinion|April 7, 2025
Management and mitigation of metabolic bone disease and cardiac adverse events throughout the prostate cancer pathway: clinical review and practical recommendationsLawrence Drudge-Coates, Patrick Davey, Julia Murray, et al.
Internal and Emergency Medicine|July 23, 2025
Effect of a multi-component palliative care intervention on goals of care discussions for critical patients in the emergency departmentJulia Murray, Zacharia Grami, Katherine Benson, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 26, 2015
Comparison of CT number calibration techniques for CBCT-based dose calculationAlex Dunlop, Dualta McQuaid, Simeon Nill, et al.
Cancers|June 19, 2024
Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction TreatmentsRosalyne Westley, Francis Casey, Adam Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2025
Predictors of Long-Term Disease-Free Survival With Stereotactic Body Radiation Therapy for Oligometastatic Prostate CancerBinnaz Yasar, Ewan Chapman, Helen Taylor, et al.
Clinical and Translational Radiation Oncology|June 14, 2024
Weekly ultra-hypofractionated radiotherapy in localised prostate cancerNora Sundahl, Douglas Brand, Chris Parker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 26, 2016
Slice Encoding for Metal Artefact Correction in magnetic resonance imaging examinations for radiotherapy planningMaria A Schmidt, Rafal Panek, Ruth Colgan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 23, 2022
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE TrialAlison C Tree, Laura Satchwell, Emma Alexander, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical and Translational Radiation Oncology|July 26, 2019
Prostate cancer - Advantages and disadvantages of MR-guided RTJulia Murray, Alison C Tree
Frontiers in Oncology|February 27, 2026
Hydraulic endorectal actuator for prostate radiotherapy reduces variations in motion in a silicone rectal phantomAryan Niknam Maleki, Mark Runciman, Julia Murray, et al.
Current Medical Research and Opinion|April 7, 2025
Management and mitigation of metabolic bone disease and cardiac adverse events throughout the prostate cancer pathway: clinical review and practical recommendationsLawrence Drudge-Coates, Patrick Davey, Julia Murray, et al.
Internal and Emergency Medicine|July 23, 2025
Effect of a multi-component palliative care intervention on goals of care discussions for critical patients in the emergency departmentJulia Murray, Zacharia Grami, Katherine Benson, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 26, 2015
Comparison of CT number calibration techniques for CBCT-based dose calculationAlex Dunlop, Dualta McQuaid, Simeon Nill, et al.
Cancers|June 19, 2024
Stereotactic Body Radiotherapy (SBRT) to Localised Prostate Cancer in the Era of MRI-Guided Adaptive Radiotherapy: Doses Delivered in the HERMES Trial Comparing Two- and Five-Fraction TreatmentsRosalyne Westley, Francis Casey, Adam Mitchell, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2025
Predictors of Long-Term Disease-Free Survival With Stereotactic Body Radiation Therapy for Oligometastatic Prostate CancerBinnaz Yasar, Ewan Chapman, Helen Taylor, et al.
Clinical and Translational Radiation Oncology|June 14, 2024
Weekly ultra-hypofractionated radiotherapy in localised prostate cancerNora Sundahl, Douglas Brand, Chris Parker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 26, 2016
Slice Encoding for Metal Artefact Correction in magnetic resonance imaging examinations for radiotherapy planningMaria A Schmidt, Rafal Panek, Ruth Colgan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 23, 2022
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE TrialAlison C Tree, Laura Satchwell, Emma Alexander, et al.
Pageof 3